Home » Newsletters » BioWorld Science

BioWorld Science

April 23, 2021

View Archived Issues

CVL-231 safe in healthy volunteers; evaluation in schizophrenia patients ongoing

Studies reveal activity, mechanism of TAM kinase inhibitor PF-5807

Phase III study finds Xywav improves excessive daytime sleepiness

Observational study confirms good tolerability and efficacy of Intratect

Second pivotal study of IDP-126 achieves all coprimary endpoints with statistical significance

First patient dosed in investigator-initiated study of rigosertib in RDEB-associated SCC

Monopteros initiates phase I/Ib study of MPT-0118 in solid tumors

Phase III JUPITER-06 study of toripalimab plus chemotherapy meets primary endpoints

Medshine Discovery divulges PD-1/PD-L1 interaction inhibitors

Chinese investigators disclose HGFR and/or SRC and/or CSF1R inhibitors

Roche presents HBsAg secretion inhibitors

Alladapt initiates phase I/II Harmony Study of ADP-101

Shanghai Litedd identifies new ROR-gammaT agonists

Tolremo Therapeutics describes new DYRK1B inhibitors

Phase II trial of selective oral DHODH modulator vidofludimus in RRMS

FDA grants accelerated approval to Jemperli for dMMR endometrial cancer

ProtoKinetix resumes phase I trials of PKX-001-treated islet cells in patients with type 1 diabetes

ICAM-1 orchestrates radiotherapy abscopal effect

Discovery of JBI-1527, small molecule inhibitor of PD-L1/PD-1 interaction

OR-2805: a novel antibody targeting CD163 for the treatment of lung cancers

Zenith agrees with Astellas to study ZEN-3694 with enzalutamide in metastatic CRPC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...